These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28929869)

  • 41. Universal healthcare coverage, Canadian style.
    Mann W
    Adm Radiol; 1992 Apr; 11(4):21-3, 25. PubMed ID: 10118529
    [No Abstract]   [Full Text] [Related]  

  • 42. National health insurance in America--can we practice with it? Can we continue to practice without it?
    Grumbach K
    West J Med; 1989 Aug; 151(2):210-6. PubMed ID: 2672604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Pharmacare in Canada".
    Acri Née Lybecker KML
    Int J Health Policy Manag; 2021 Mar; 10(3):152-154. PubMed ID: 32610780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug costs in Canada.
    Fuller S
    Health Aff (Millwood); 2003; 22(4):259. PubMed ID: 12889774
    [No Abstract]   [Full Text] [Related]  

  • 45. Federal budget disappoints on universal pharmacare.
    Vogel L
    CMAJ; 2019 Apr; 191(14):E406-E407. PubMed ID: 30962204
    [No Abstract]   [Full Text] [Related]  

  • 46. [Proposal to a national family practice system is not compatible with the legal right to access to health service].
    Järhult B
    Lakartidningen; 2003 Jan; 100(3):150-1. PubMed ID: 12596483
    [No Abstract]   [Full Text] [Related]  

  • 47. Universal prescription drug coverage in Canada: Long-promised yet undelivered.
    Morgan SG; Boothe K
    Healthc Manage Forum; 2016 Nov; 29(6):247-254. PubMed ID: 27744279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicare's Evolution: National Pharmacare and Shared Leadership.
    Nemis-White J; Torr E; Aylen J; Gogovor A; Martin L; Mitchell J; MacPherson N; Montague T
    Healthc Q; 2019 Jul; 22(2):15-19. PubMed ID: 31556374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hard decisions about fundamental values.
    Laupacis A
    Healthc Pap; 2004; 4(3):60-6; discussion 68-72. PubMed ID: 15114071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using clinically nuanced cost sharing to enhance consumer access to specialty medications.
    Buxbaum J; de Souza J; Fendrick AM
    Am J Manag Care; 2014 Jun; 20(6):e242-4. PubMed ID: 25180506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A response to stories about wait times for medical procedures.
    Faguy P
    Healthc Q; 2005; 8(1):9-10. PubMed ID: 15715326
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
    Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
    J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poverty and pain: ethics and the lack of opioid pain medications in fixed-price, low-cost prescription plans.
    Graber MA; Easton-Carr R
    Ann Pharmacother; 2008 Dec; 42(12):1913-4. PubMed ID: 19033486
    [No Abstract]   [Full Text] [Related]  

  • 54. Home care and prescription drugs to be funded under medicare.
    Garmaise D
    Can HIV AIDS Policy Law Rev; 2003 Apr; 8(1):25. PubMed ID: 12924293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Regulators in access to anticancer drugs in Canada].
    Côté A; Keating B; Parent M; Simard G
    Sante Publique; 2015; 27(4):515-27. PubMed ID: 26751926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacare for children slow to gain ground in NS.
    Moulton D
    CMAJ; 2007 Apr; 176(8):1073. PubMed ID: 17420487
    [No Abstract]   [Full Text] [Related]  

  • 57. Norway backs downs over plan to exclude anticancer drugs from coverage.
    Hansen A
    BMJ; 2013 Mar; 346():f1707. PubMed ID: 23491458
    [No Abstract]   [Full Text] [Related]  

  • 58. To build a wooden horse...integrating drugs into the public health system.
    Forest PG
    Healthc Pap; 2004; 4(3):22-6; discussion 68-72. PubMed ID: 15114065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving access to medicines in urban, regional and rural Aboriginal communities--is expansion of Section 100 the answer?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(2):738. PubMed ID: 17590140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medication coverage for lawmakers may worsen access for everyone else.
    Taglione MS; Boozary A; Persaud N
    Prev Med; 2018 Mar; 108():67-73. PubMed ID: 29289641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.